259 related articles for article (PubMed ID: 23100622)
21. On the biotech block.
Ossola A
Nature; 2017 Oct; 550(7676):S168-S171. PubMed ID: 29045361
[No Abstract] [Full Text] [Related]
22. What research should the Arthritis and Rheumatism Council be funding?
Dieppe P
Br J Rheumatol; 1992 Oct; 31(10):649-50. PubMed ID: 1393368
[No Abstract] [Full Text] [Related]
23. Life sciences and biotechnology in China.
Chen Z; Wang HG; Wen ZJ; Wang Y
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):947-57. PubMed ID: 17331895
[TBL] [Abstract][Full Text] [Related]
24. Finnish biotechnology--built on solid foundations.
Lähteenmäki R
Nature; 2002 Dec; 420(6916 Suppl):A34-5, A37, A39. PubMed ID: 12501125
[No Abstract] [Full Text] [Related]
25. Canadian lab loses Amgen backing.
Knight J
Nature; 2002 May; 417(6884):4. PubMed ID: 11986629
[No Abstract] [Full Text] [Related]
26. Life science facilities in crisis as Brussels switches off funding.
Butler D
Nature; 1999 Nov; 402(6757):3-4. PubMed ID: 10573401
[No Abstract] [Full Text] [Related]
27. Biotech in Italy.
Biotechnol J; 2007 Mar; 2(3):298-300. PubMed ID: 17354217
[No Abstract] [Full Text] [Related]
28. Florida lures research institutes east.
Dalton R
Nature; 2006 Aug; 442(7104):729. PubMed ID: 16915254
[No Abstract] [Full Text] [Related]
29. Life sciences: all jazzed up.
Mascarelli A
Nature; 2012 Jun; 486(7403):429-31. PubMed ID: 22730564
[No Abstract] [Full Text] [Related]
30. UK research funding.
Nat Cell Biol; 2009 Apr; 11(4):363. PubMed ID: 19337316
[No Abstract] [Full Text] [Related]
31. Technology and financing strategies in the development of life science companies.
Gertler JP; Hu A; Simon J
Surgery; 2008 Feb; 143(2):198-205. PubMed ID: 18242336
[No Abstract] [Full Text] [Related]
32. Why French politics and science don't mix.
Nat Mater; 2004 May; 3(5):275. PubMed ID: 15122212
[No Abstract] [Full Text] [Related]
33. US science policy: upstart states.
Marris E
Nature; 2005 Mar; 434(7029):10-2. PubMed ID: 15744265
[No Abstract] [Full Text] [Related]
34. An embargoed Cuban science.
Smith C
Genet Anal; 1999 Nov; 15(3-5):71-2. PubMed ID: 10596742
[No Abstract] [Full Text] [Related]
35. Singapore. Winds of change leave bioscientists scrambling.
Normile D
Science; 2011 Apr; 332(6026):165. PubMed ID: 21474727
[No Abstract] [Full Text] [Related]
36. Reforming the Russian Academy of Sciences.
Clark F
Lancet; 2013 Oct; 382(9902):1392-3. PubMed ID: 24206608
[No Abstract] [Full Text] [Related]
37. Priorities and funding. "Knowledge innovation" and the Chinese Academy of Sciences.
Suttmeier RP; Cao C; Simon DF
Science; 2006 Apr; 312(5770):58-9. PubMed ID: 16601178
[No Abstract] [Full Text] [Related]
38. Life support for life science innovation?
Nat Biotechnol; 2007 Feb; 25(2):144. PubMed ID: 17287731
[TBL] [Abstract][Full Text] [Related]
39. A new global strategy for the life sciences in Europe.
van Dyck L
EMBO Rep; 2005 Mar; 6(3):194-7. PubMed ID: 15741967
[TBL] [Abstract][Full Text] [Related]
40. Nurturing bioincubators in the north.
Russo G
Nature; 2006 Jun; 441(7094):782. PubMed ID: 16832858
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
